Search Results 661-670 of 17002 for monoclonal antibody
Monoclonal antibodies, such as cetuximab, can interfere with tumor growth by blocking the ability of tumor cells to grow and spread. Tivantinib may stop the ...
Risk for Postmarket Black Box Warnings in FDA-Approved Monoclonal Antibodies. ... Pneumococcal serotype-specific cut-offs based on antibody responses to ...
About this study. The purpose of this study is to determine the safety profile, maximum tolerable dose (MTD) and cohort expansion of single-agent GBR 1342 ...
Monoclonal antibodies, such as atezolizumab, may block specific proteins found on white blood cells which may strengthen the immune system and control tumor ...
History of clinically significant hypersensitivity associated with monoclonal antibody therapies or components of the emicizumab injection. Eligibility last ...
The purpose of this study is to investigate how efficiently the study medication imlifidase reduces the amount of donor specific antibodies (DSA) in comparison ...
... monoclonal antibody. * Arm B: Must have received at least 2 or more lines of therapy, including exposure to a PI, an IMiD, an anti-CD38 monoclonal ...
Monoclonal antibodies, such as alemtuzumab, can bind to and kill malignant lymphocytes. ... The biomarker and antibody results along with your personal ...
The anti-CD52 monoclonal antibody alemtuzumab reduces disease activity in previously untreated patients with relapsing-remitting multiple sclerosis. We ...
-History of severe allergic or anaphylactic reactions to monoclonal antibody therapy (or recombinant antibody-related fusion proteins) -Patient with history ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.